Q1 2020 Bristol-Myers Squibb Co Earnings Call Transcript
Good day, and welcome to the Bristol-Myers Squibb 2020 First Quarter Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead.
Thanks, Chloe, and good morning, everyone. Thanks for joining us this morning for our first quarter 2020 earnings call. Joining me this morning with prepared remarks are Giovanni Caforio, our Chairman and Chief Executive Officer; and David Elkins, our Chief Financial Officer. Also participating in today's call for the Q&A session are Chris Boerner, our Chief Commercialization Officer; Nadim Ahmed, President, Hematology; and Samit Hirawat, our Chief Medical Officer and Head of Global Drug Development. As you'll note, we've posted slides at bms.com that you can use to follow along with for David and Giovanni's remarks.
But before we get started, I'll read our forward-looking statements. During this call, we'll make statements about
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
